TARS stock

Tarsus Pharmaceuticals Inc (TARS) revenue is $118.7M

Tarsus Pharmaceuticals Inc (TARS) revenue is $118.7M as of 2025-09-30. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.

Read the full TARS research page for quote, filings, and the rest of the model. This satellite exists so “Tarsus Pharmaceuticals Inc revenue” can rank with the actual number, then send you to /stock/tars.

Full TARS analysis